The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...

For some common medical conditions, timing is everything when it comes to taking medications. Now, a customizable capsule ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release Tablets. The Tribune, now published from ...

a strip search later revealed more Pregabalin tablets stashed in his boxer shorts. Text messages on his phone showed details of his latest drug deals. When Burton was caught, he told the police ...

has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release Tablets. Niacin is indicated to reduce elevated total cholesterol (TC ...

There are currently no drugs approved in the European Union to treat the liver condition known as MASH, but a new trial of ...

Alembic Pharmaceuticals on Friday said it has received approval from the US health regulator to market a generic medication for the prevention of heart attack and stroke. The company has received ...

New Delhi [India], April 30 (ANI): Indian multinational pharmaceutical company, Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to ...

Leniolisib for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and over HST33 23 April 2025 23 April 2025 ...